Octreotide Efficacy and Safety in First-line Acromegalic Patients
Clinical trial NCT00171886 · COMPLETED
Trial details
- NCT number
- NCT00171886
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2006-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.